Welcome
KMT2C Foundation x Citizen Health
proudly announce their 2025 partnership!
Welcome
KMT2C Foundation x Citizen Health
proudly announce their 2025 partnership!
KMT2C Foundation x Citizen Health
proudly announce their 2025 partnership!
KMT2C Foundation x Citizen Health
proudly announce their 2025 partnership!
KMT2C Foundation was established in 2025 as a nonprofit organization, and is incorporated in Texas, USA. The Foundation started as a virtual community for USA-based parents who have a loved one who is diagnosed with a KMT2C chromosonal abnormality. Chromosonal abnormalities include but are not limited to mutations, deletions, truncations, and insertions. The KMT2C Foundation stands with the Global Genes Global Advocacy Alliance to represent our families while championing KMT2C research and community.
Our virtual community started with a humble count of three domestic familes across the United States. As of February 2025, the Foundation now proudly represents over fifty-one families on and offline and over fifty-six diagnosed individuals ranging from sixteen weeks old to seventy-one years old.
KMT2C Foundation is proud to partner with Citizen Health this Spring 2025. We will be establishing the first natural history study (NHS). In January 2025 we participated in the Simons Searchlight Shine Your Searchlight campaign to help build a DNA biorepository.
Over thirteen years of industry experience within FinTech and bio-pharma operations. Start-up involvement has been from seed stage to fully funded with pharmaceutical backing. Teams have included c-suite members and senior executives from North America, EMEA, LATAM, Switzerland, APAC, and India. Mrs. Koch is the founding member of the KMT
Over thirteen years of industry experience within FinTech and bio-pharma operations. Start-up involvement has been from seed stage to fully funded with pharmaceutical backing. Teams have included c-suite members and senior executives from North America, EMEA, LATAM, Switzerland, APAC, and India. Mrs. Koch is the founding member of the KMT2C Foundation. She is a long-standing children's advocate and rare disease research advocate.
Alisa Mo received her M.D., Ph.D. at Johns Hopkins University School of Medicine in Baltimore, Maryland and is currently a Child Neurology resident at Boston Children’s Hospital. She is interested in better understanding the genetic and epigenetic basis of neurodevelopmental diseases, with a particular focus on defects in chromatin-related genes.
Julie L. Thompson, PhD, BCBA-D, is an Associate Professor of Special Education, Behavioral Learning INterventions in Children (BLINC) Lab Director; Core Faculty Member of the Texas A&M University Institute for Early Childhood Development and Education; and Affiliated Faculty Member of the Center on Disability and Development at Texas A&M
Julie L. Thompson, PhD, BCBA-D, is an Associate Professor of Special Education, Behavioral Learning INterventions in Children (BLINC) Lab Director; Core Faculty Member of the Texas A&M University Institute for Early Childhood Development and Education; and Affiliated Faculty Member of the Center on Disability and Development at Texas A&M University. Julie’s work as a classroom teacher for children with autism spectrum disorder (ASD) gave her insight into the layered complexities of providing adequate education to individuals with ASD in public schools. Julie’s BLINC lab uses social-justice-driven mixed-methods research to specialize in two areas: academic instruction for students with profound autism and/or intellectual disabilities AND preventing and teaching replacement behaviors to students with interfering problem behaviors in the classroom, to support inclusion, communication, independence, and lifelong fulfillment. Julie has been PI on seven externally funded awards totaling $3,864,799 and Co-PI four externally funded awards totaling $30.14 million. Julie has 22 peer-reviewed publications, 58 peer-reviewed presentations, and has chaired or co-chaired 17 doctoral students.
Community Engagement Lead
Community Engagement
Community Engagement
Community Engagement
Community Engagement
Statewide within Texas
Statewide within Texas
College Station City Hall
The Foundation invites you to join us at City Hall as we read a joint proclamation on developmental disability awareness with the Texas Coun...
College Station City Hall
Virtual
We welcome you to pre-register and join the KMT2C Foundation as we discuss the latest publications on the KMT2C chromosone with clinical res...
Virtual
Virtual
We welcome you to pre-register and join the KMT2C Foundation as we discuss the latest publications on the KMT2C chromosone with clinical res...
Virtual
We are proud to share an exciting partnership between the KMT2C Foundation and Citizen Health. Together, we are building critical natural history studies that will give researchers access to the real-world data they need to ask bigger questions, uncover patterns, and explore meaningful solutions. A natural history study tracks the progression of a medical condition over a prolonged period of time.
The KMT2C Foundation x Citizen Health Natural History Study Campaign has is fully digital. Participation is done through an online portal, and data can be securely organized and shared.
Yes, AND all data is properly protected and confidentiality is maintained in accordance with United States HIPAA law. HIPAA law is also why there will be consent forms for every single health care campaign. Terms and conditions are adhered to by the highest set of standards.
Yes! In fact, our Board MD will be creating stem cell lines from the blood samples within our KMT2C biorepository. Our community's DNA is quite literally part of the research that will hopefully lead to future treatment.
KMT2C Foundation was founded in 2025 as an American Parent Advocacy Group, and operates out of Texas. Since establishment in 2025, the KMT2C Foundation has completed one campaign with Simons Searchlight (February 2025 Shine Your Searchlight) in an effort to build a biorepository. This March 2025, the KMT2C Foundation will host it's second campaign with Citizen Health to build a natural history study.
The KMT2C Foundation doesn't plan to host international campaigns at this time. However, international patients and parents are strongly encouraged to establish Patient Advocacy Groups within their respective countries. A PAG recognized with an EIN/ established nonprofit entity can partner with the KMT2C Foundation, advocate your respective local government, and help you build a community overseas with the opportunity to partner on future conferences. If you have questions regarding the steps taken to establish a PAG, we are happy to provide the same resources that guided our Foundation.
info@kmt2c.org
Stay up to date on research opportunities, and community events!
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.